Baxter International (NYSE:BAX) Stock Unloaded Rep. Lisa C. McClain

Key Points

• Representative Lisa C. McClain sold shares of Baxter International (NYSE:BAX) worth between $1,001 and $15,000 on August 4th, as disclosed in a filing on September 12th.
• Baxter International recently reported a quarterly loss of $0.59 EPS, missing analysts' estimates, and set Q3 2025 guidance at 0.580-0.620 EPS.
• The company announced a quarterly dividend of $0.17 per share, with a yield of 2.8%, despite having a payout ratio of -226.67%.

Representative Lisa C. McClain (R-Michigan) recently sold shares of Baxter International Inc. NYSE: BAX. In a filing disclosed on September 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Baxter International stock on August 4th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $50,001 - $100,000 in shares of Taiwan Semiconductor Manufacturing NYSE: TSM on 8/28/2025.
• Purchased $1,001 - $15,000 in shares of ACI Worldwide NASDAQ: ACIW on 8/19/2025.
• Purchased $1,001 - $15,000 in shares of HCA Healthcare NYSE: HCA on 8/19/2025.
• Sold $1,001 - $15,000 in shares of Amedisys NASDAQ: AMED on 8/18/2025.
• Purchased $1,001 - $15,000 in shares of Kite Realty Group Trust NYSE: KRG on 8/13/2025.
• Sold $1,001 - $15,000 in shares of ServiceNow NYSE: NOW on 8/13/2025.
• Purchased $1,001 - $15,000 in shares of JD.com NASDAQ: JD on 8/13/2025.
• Sold $1,001 - $15,000 in shares of Trade Desk NASDAQ: TTD on 8/13/2025.
• Sold $1,001 - $15,000 in shares of US Foods NYSE: USFD on 8/13/2025.
• Purchased $1,001 - $15,000 in shares of Agree Realty NYSE: ADC on 8/13/2025.

Baxter International Price Performance

Shares of NYSE:BAX opened at $23.88 on Wednesday. The company has a current ratio of 2.30, a quick ratio of 1.49 and a debt-to-equity ratio of 1.30. Baxter International Inc. has a 12 month low of $21.33 and a 12 month high of $40.49. The stock has a market cap of $12.27 billion, a P/E ratio of -79.60, a P/E/G ratio of 0.78 and a beta of 0.61. The company has a 50 day moving average of $25.35 and a 200 day moving average of $29.20.

Baxter International (NYSE:BAX - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $0.59 EPS for the quarter, missing analysts' consensus estimates of $0.60 by ($0.01). The company had revenue of $2.81 billion during the quarter, compared to analysts' expectations of $2.82 billion. Baxter International had a positive return on equity of 16.96% and a negative net margin of 1.42%.Baxter International's quarterly revenue was up 4.3% on a year-over-year basis. During the same period in the prior year, the firm earned $0.68 EPS. Baxter International has set its Q3 2025 guidance at 0.580-0.620 EPS. FY 2025 guidance at 2.420-2.520 EPS. As a group, sell-side analysts forecast that Baxter International Inc. will post 2.48 EPS for the current fiscal year.

Baxter International Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 1st. Investors of record on Friday, August 29th will be paid a dividend of $0.17 per share. The ex-dividend date of this dividend is Friday, August 29th. This represents a $0.68 annualized dividend and a yield of 2.8%. Baxter International's payout ratio is currently -226.67%.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on BAX shares. Wells Fargo & Company reduced their target price on shares of Baxter International from $33.00 to $24.00 and set an "equal weight" rating on the stock in a research report on Friday, August 1st. UBS Group cut their price objective on shares of Baxter International from $35.00 to $24.00 and set a "neutral" rating on the stock in a research report on Monday, August 4th. Evercore ISI cut their price objective on shares of Baxter International from $44.00 to $42.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. Barclays cut their price objective on shares of Baxter International from $41.00 to $36.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Finally, Morgan Stanley cut their price objective on shares of Baxter International from $28.00 to $27.00 and set an "underweight" rating on the stock in a research report on Tuesday, July 15th. Three research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $30.11.

Institutional Trading of Baxter International

Several hedge funds have recently modified their holdings of BAX. Mufg Securities Americas Inc. purchased a new position in shares of Baxter International in the 4th quarter valued at approximately $220,000. Raiffeisen Bank International AG purchased a new position in shares of Baxter International in the 4th quarter valued at approximately $2,193,000. Public Employees Retirement System of Ohio purchased a new position in shares of Baxter International in the 4th quarter valued at approximately $5,102,000. GF Fund Management CO. LTD. purchased a new position in shares of Baxter International in the 4th quarter valued at approximately $365,000. Finally, MassMutual Private Wealth & Trust FSB raised its position in shares of Baxter International by 48.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 2,021 shares of the medical instruments supplier's stock valued at $69,000 after purchasing an additional 656 shares during the last quarter. 90.19% of the stock is owned by hedge funds and other institutional investors.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.